Back
AngioDynamics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
49
ANGO
AngioDynamics
Last Price:
$8.90
Seasonality Move:
-1.12%
Sell
23
CATX
Perspective Therapeutics
Last Price:
$2.87
Seasonality Move:
41.25%
Sell
49
AngioDynamics (ANGO)
is a Sell
Is AngioDynamics a Buy, Sell or Hold?
-
The current AngioDynamics [ANGO] share price is $8.89. The Score for ANGO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
ANGO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
-
The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANGO Stock Price Chart
What is AngioDynamics's stock price today?
-
The AngioDynamics share price today is $8.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANGO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $2.85Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
ANGO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.54 | Buy |
Relative Strength Index (14 RSI): | 64.18 | Buy |
Chaikin Money Flow: | 398181 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.76 - 8.78) | Buy |
Bollinger Bands (100): | (6.63 - 8.05) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.39 | Sell |
Relative Strength Index (14 RSI): | 19.38 | Sell |
Chaikin Money Flow: | -1073375 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.81 - 5.45) | Sell |
Bollinger Bands (100): | (6.71 - 15.03) | Sell |
ANGO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.03 | Sell |
20-day SMA: | 8 | Buy |
50-day SMA: | 7.3 | Buy |
200-day SMA: | 6.75 | Buy |
8-day EMA: | 8.79 | Buy |
20-day EMA: | 8.24 | Buy |
50-day EMA: | 7.64 | Buy |
200-day EMA: | 7.19 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.2 | Sell |
20-day SMA: | 3.62 | Sell |
50-day SMA: | 7.97 | Sell |
200-day SMA: | 12.2 | Sell |
8-day EMA: | 3.18 | Sell |
20-day EMA: | 4.2 | Sell |
50-day EMA: | 6.97 | Sell |
200-day EMA: | 10.02 | Sell |
AngioDynamics Earnings Growth & ANGO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and an increase next year of $0.12 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
AngioDynamics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |